Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled time : 20:00 source : Www.biospace.com save search
Windtree Therapeutics Announces Reverse Stock Split - April 18, 2024
Published: 2024-04-18 (Crawled : 20:00) - biospace.com/
WINT | News | $0.3399 -15.3% -18.06% 1.8M
|
Health Technology
|
| O: -30.25%
H: 0.0%
C: 0.0%
therapeutics
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - April 18, 2024
Published: 2024-04-18 (Crawled : 20:00) - biospace.com/
SDGR | News | $24.37 -2.68% -2.75% 670K
|
Technology Services
|
| O: 0.38%
H: 0.0%
C: 0.0%
nasdaq grants
Legend Biotech to Host Investor Conference Call on First Quarter 2024 Results
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
LEGN | $47.16 -3.42% -3.54% 820K
|
Health Technology
|
| O: 0.02%
H: 0.22%
C: -0.88%
first conference biotech results
PTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial Results
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
PTCT | $24.71 -1.79% -1.82% 820K
|
Health Technology
|
| O: 2.01%
H: 1.35%
C: -0.18%
first conference therapeutics financial results
Pfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting of Shareholders on April 25
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: 0.11%
H: 0.38%
C: -0.04%
meeting
FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Sudan Ebolavirus Infection
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
SNGX | $0.42 -17.65% -21.43% 6.3M
|
Health Technology
|
| O: 3.67%
H: 0.46%
C: -19.02%
fda drug infection designation for grants
Citius Pharmaceuticals Announces Addition of City of Hope to UMN's Phase 1 Trial of LYMPHIR in Combination with CAR-T for the Treatment of B-Cell Lymphoma
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 34K
|
Communications
|
| O: -100.0%
H: NaN%
C: Infinity%
GILD | News | $66.16 -1.15% -1.16% 6.4M
|
Health Technology
|
| O: 0.5%
H: 0.83%
C: 0.28%
CTXR | $0.8 -1.99% -2.02% 6.3M
|
Health Technology
|
| O: 2.33%
H: 2.28%
C: -4.23%
hope treatment pharmaceuticals city for car-t trial
Blueprint Medicines to Host Webcast and Conference Call Highlighting Emerging Opportunities for Mast Cell-Targeted Therapeutics
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
BPMC | News | $88.9 0.59% 0.58% 730K
|
Health Technology
|
| O: 1.08%
H: 1.19%
C: 0.85%
conference for therapeutics
Orna Therapeutics Appoints Frank Neumann, M.D., Ph.D., as Chief Medical Officer
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
VSTM | $10.19 -6.0% -6.38% 67K
|
Health Technology
|
| O: -0.4%
H: 4.84%
C: 4.79%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.05%
H: 0.0%
C: 0.0%
medical therapeutics
Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
CRL | $227.55 -1.1% 0.0% 710K
|
Commercial Services
|
| O: 0.48%
H: 0.0%
C: 0.0%
for
Black Diamond Therapeutics Announces Changes to Board of Directors - April 11, 2024
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
BDTX A | $5.295 -7.11% -7.65% 1.9M
|
Health Technology
|
| O: -3.01%
H: 11.9%
C: 11.4%
therapeutics
bluebird bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
BLUE | $0.9583 -0.52% -0.52% 6.5M
|
Health Technology
|
| O: 1.68%
H: 1.65%
C: -4.13%
nasdaq grants
Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
APVO 3 d | $0.76 6.67% 6.25% 220K
|
Health Technology
|
| O: -59.52%
H: 0.0%
C: 0.0%
million offering therapeutics
Leap Therapeutics Announces $40 Million Private Placement
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
LPTX | $2.96 -1.33% -1.35% 100K
|
Health Technology
|
| O: 15.13%
H: 25.43%
C: -11.0%
GILD | News | $66.16 -1.15% -1.16% 6.4M
|
Health Technology
|
| O: 0.5%
H: 0.83%
C: 0.28%
million leap therapeutics
Merck, Essential Pharma, CoreRx and More Continue 2024 M&A Upswing
Published: 2024-04-09 (Crawled : 20:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.3%
H: 0.0%
C: 0.0%
Biopharma Layoff Tracker 2024: Sanofi, Boehringer, Carisma and More Cut Staff
Published: 2024-04-05 (Crawled : 20:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -1.77%
H: 0.0%
C: -1.81%
RLYB | $1.68 -4.55% -4.76% 350K
|
|
| O: 0.63%
H: 3.77%
C: 2.52%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -1.84%
H: 0.0%
C: 0.0%
VXRT | $0.836 -3.48% -3.6% 880K
|
Health Technology
|
| O: -2.65%
H: 4.55%
C: -1.82%
TXMD | $1.98 4.76% 4.55% 5.7K
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: -2.43%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -3.44%
H: 0.0%
C: 0.0%
PTCT | $24.71 -1.79% -1.82% 820K
|
Health Technology
|
| O: -1.83%
H: 1.46%
C: -1.06%
NKTR | $1.3 -3.7% -3.85% 3.6M
|
Health Technology
|
| O: 0.0%
H: 11.36%
C: 0.0%
MOR | $18.02 -0.11% -0.11% 590K
|
Health Technology
|
| O: 0.06%
H: 0.17%
C: 0.0%
GLPG | $28.9 -1.1% -1.11% 140K
|
Health Technology
|
| O: -0.47%
H: 1.14%
C: 0.47%
AMRN | $0.8799 -4.06% -4.23% 1M
|
Health Technology
|
| O: -2.83%
H: 0.0%
C: 0.0%
GOOGL | News S | $155.97 0.32% 0.32% 19M
|
Technology Services
|
| O: -2.48%
H: 2.33%
C: 1.71%
GOOG | News S | $157.49 0.39% 0.39% 14M
|
Technology Services
|
| O: -2.37%
H: 2.29%
C: 1.7%
OCX J | $2.52 -2.7% -2.78% 37K
|
Health Technology
|
| O: -3.4%
H: 2.11%
C: 2.11%
biopharma
COLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
Published: 2024-04-04 (Crawled : 20:00) - biospace.com/
CLGN | $5.11 -2.48% -2.54% 8.6K
|
Health Technology
|
| O: -0.18%
H: 0.0%
C: -2.95%
biotechnologies year update financial results
Bicara Therapeutics Expands Clinical Team with Appointments of Jeltje Schulten, M.D., MBA, as SVP of Clinical and Medical Affairs and Rita Dalal, MBBS, MPH, as VP of Clinical Development
Published: 2024-03-26 (Crawled : 20:00) - biospace.com/
MURA | $3.57 -5.05% -5.32% 240K
|
|
| O: 3.7%
H: 2.57%
C: 0.22%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.14%
H: 0.53%
C: 0.09%
medical therapeutics
Biond Biologics Announces Presentation of BND-35, a Novel Anti-ILT3 Antibody for Remodeling the Tumor Microenvironment, at the American Association for Cancer Research (AACR) 2024 Annual Meeting
Published: 2024-03-26 (Crawled : 20:00) - biospace.com/
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.93%
H: 0.0%
C: 0.0%
bnd-35 antibody association presentation cancer tumor research meeting
New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can be Effectively Treated in 5 Days Using the Accuray CyberKnife® System
Published: 2024-03-26 (Crawled : 20:00) - biospace.com/
ARAY | $2.21 0.91% 0.9% 690K
|
Health Technology
|
| O: -0.81%
H: 1.46%
C: -3.66%
cyberknife indicate system
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.